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Cryptochromes regulate the circadian clock in animals and plants.
Humans and mice have two cryptochrome (Cry) genes. A previous
study showed that mice lacking the Cry2 gene had reduced sen-
sitivity to acute light induction of the circadian gene mPer1 in the
suprachiasmatic nucleus (SCN) and had an intrinsic period 1 hr
longer than normal. In this study, Cry12y2 and Cry12y2Cry22y2
mice were generated and their circadian clocks were analyzed at
behavioral and molecular levels. Behaviorally, the Cry12y2 mice
had a circadian period 1 hr shorter than wild type and the
Cry12y2Cry22y2 mice were arrhythmic in constant darkness (DD).
Biochemically, acute light induction of mPer1 mRNA in the SCN was
blunted in Cry12y2 and abolished in Cry12y2Cry22y2 mice. In
contrast, the acute light induction of mPer2 in the SCN was intact
in Cry12y2 and Cry12y2Cry22y2 animals. Importantly, in double
mutants, mPer1 expression was constitutively elevated and no
rhythmicity was detected in either 12-hr lighty12-hr dark or DD,
whereas mPer2 expression appeared rhythmic in 12-hr lighty12-hr
dark, but nonrhythmic in DD with intermediate levels. These
results demonstrate that Cry1 and Cry2 are required for the normal
expression of circadian behavioral rhythms, as well as circadian
rhythms of mPer1 and mPer2 in the SCN. The differential regulation
of mPer1 and mPer2 by light in Cry double mutants reveals a
surprising complexity in the role of cryptochromes in mammals.
gene targeting u photoreceptor u suprachiasmatic nucleus
C ircadian rhythms are oscillations with daily periodicities inphysiological and behavioral functions of organisms (1–3).
The rhythms are generated by a cell-autonomous circadian
oscillator (4) that is synchronized with the environment by light.
Recently, it was proposed that, in mammals, the nonopsin
pigments, cryptochrome blue-light photoreceptors (5, 6), may be
the photoactive pigments that synchronized the molecular os-
cillator and, ultimately, the organismic circadian rhythm with the
daily light–dark cycle (7, 8). In humans and mice there are two
genes encoding the apoproteins of the cryptochromes: CRY1 and
CRY2 in humans and Cry1 and Cry2 in mice (6, 8, 9). Both genes
are expressed throughout the body (8–11). Of particular interest,
both Cry1 and Cry2 are expressed at high levels in the ganglion
cells and the inner nuclear layer of the retina, which are known
to be important for circadian photoreception, and Cry1 is
expressed with a robust circadian rhythm in the suprachiasmatic
nucleus (SCN) (8).
In a previous study (12), we found that mice lacking a
functional Cry2 gene (i) had reduced sensitivity to acute light
induction of the clock gene mPer1 (mouse period gene 1) in the
SCN, (ii) had an intrinsic circadian period about 1 hr longer than
normal, and (iii) exhibited high amplitude phase shifts in re-
sponse to light pulses administered at circadian time (CT) 17.
These data, and related findings in cryptochrome mutants of
Drosophila melanogaster (13) and Arabidopsis thaliana (14),
supported the notion that cryptochromes are major photorecep-
tors for circadian entrainment in animals and plants. Further-
more, the longer than wild-type circadian period in Cry22y2 mice
under constant darkness (DD) and their high-amplitude phase
shifts both suggested that cryptochromes could also (or instead)
be part of the molecular clock that generates circadian period-
icity independently of light (12). That the Cry22y2 mice could be
entrained to a 12-hr lighty12-hr dark (LD12:12) cycle indicated
that the CRY1 protein or other pigments, in addition to the
CRY2 protein, participated in photoentrainment. Indeed, in
Drosophila, genetic evidence indicates that both the f la-
vinypterin-based cryptochrome and the retinal-based rhodopsin
contribute to circadian photoentrainment (13, 15, 16).
To learn about the roles of cryptochromes in the circadian
system, mutant mice lacking CRY1, CRY2, or both CRY1 and
CRY2 proteins have been generated and analyzed. Our data
show that Cry12y2 mice had circadian periods shorter than wild
type and Cry12y2Cry22y2 mice were arrhythmic under DD.
Biochemically, the mPer1 transcript in the SCN exhibited day–
night differences but was poorly induced at Zeitgeber time (ZT)
18 in Cry12y2 mice and was chronically elevated and not
inducible with acute light pulses in Cry12y2Cry22y2 mice. In
contrast, the mPer2 transcript levels in the SCN exhibited robust
day–night differences and light induction in both Cry12y2 and
Cry12y2Cry22y2 mice. Under DD conditions, both mPer1 and
mPer2 levels in the SCN were at constant levels in the
Cry12y2Cry22y2 mice; mPer1 was elevated and mPer2 was
intermediate. These data provide a molecular explanation for
the arrhythmicity in the double mutant we have observed in this
study as well as a study that was published (17) while this
manuscript was in preparation. Importantly, our data indicate
that CRY1 and CRY2 play a central role in the circadian clock
system of mammals: they are required for the expression of
sustained circadian rhythms and they differentially regulate
mPer1 and mPer2 gene expression.
Materials and Methods
Generation of Cry12y2 Mice. A full-length Cry12y2 cDNA (8) was
used to screen a l-mouse genomic library of the 129ySv strain.
Two phage clones (nos. 29 and 64) carrying genomic fragments
overlapping with Cry1 were isolated. However, the two frag-
ments did not overlap; a 13-kb spacing in the mouse genome
between the cloned sequences was identified by long PCR. The
nucleotide sequence of the ends of the two genomic fragments
revealed two exons corresponding to the cDNA sequence of
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600–685 and 1646–1715 bp in clones 29 and 64, respectively.
Thus, the 13-kb genomic region contains exons corresponding to
cDNA sequence 686–1646, which includes the region encoding
the FAD-binding domain of the protein (18). We constructed a
plasmid (p8529164) that lacked this 13-kb genomic region by
subcloning the entire genomic fragment of clone 29 (the 59 arm)
and a 1.5-kb SalIyXhoI fragment of clone 64 (the 39 arm) into
the NotI and XhoI sites, respectively, of pBluescript. To construct
the targeting vector, a 6.7-kb SalI fragment of the plasmid
pGT1.8IresBgeo containing the En2-derived splice acceptor and
the IresLacZ-Neo fusion gene (19) was subcloned into the SalI
site of pB529y64. The final construct is shown in Fig. 1 A.
The targeting vector (100 mg) was linearized with XhoI and
electroporated into E14tg2a embryonic stem cells (20). Electro-
porated cells were cultured in the presence of 150 mgyml G418
(GIBCO) for 8 days; G418-resistant clones were picked and
genotyped by Southern hybridization. One embryonic stem
clone containing the disrupted Cry1 gene was injected into a
C57BLy6 blastocyst and transferred into pseudopregnant fe-
male recipients. The resulting chimeras were bred with
C57BLy6 females. Germ-line transmission was screened by coat
color and confirmed by Southern hybridization. By crossing
heterozygotes generated by gene targeting we obtained Cry12y2
mice.
Generation of Cry12y2Cry22y2 Mice. The Cry12y2 mice were
crossed with Cry22y2 mice (12) to obtain Cry11y2Cry21y2
progeny. The double heterozygotes then were interbred to
obtain Cry12y2Cry22y2 animals as well as double heterozygotes.
Genotyping was done both by Southern hybridization and by
PCR by using two sets of primers (one for amplifying the wild
type and the other for amplifying the disrupted gene) for each
of the Cry genes. After verifying the reliability of the PCR
genotyping, all routine screening was done by PCR.
Locomotor Activity Analysis. The experimental setup for recording
locomotor activity (wheel running) has been described previ-
ously (21–23). Activity data was recorded continuously by a PC
system (Chronobiology Kit; Stanford Software Systems, Santa
Cruz, CA) and was displayed and analyzed by using software in
the MatLab environment (ClockLab; Actimetrics, Evanston,
IL). The period in DD was measured by a x2 periodogram from
20 consecutive days when no manipulations were performed
(24). Fast Fourier transform (FFT) analysis of the same 20
consecutive days also was performed (25). The power spectral
densities for frequencies ranging from 0 to 1 cycleyhr were
determined and normalized to a total power (area under the
curve) of 1.0. This normalization, in part, corrects for individ-
uals’ differences in activity level. The peak in the circadian range
(18- to 30-hr period or 0.033–0.055 cyclesyhr) of the relative
power was determined for each animal for comparison. Effects
of genotype were analyzed by a Generalized Model (GLM)
ANOVA by using NCSS (Kayesville, UT), with Scheffe’s posthoc
tests for pairwise comparisons.
In Situ Hybridization. The oscillation of mPer1 and mPer2 mRNA
levels in the SCN of mutant mice under LD, DD, and acute light
induction conditions was quantified by in situ hybridization as
described previously (26). Animals were killed by cervical
dislocation, and brains were dissected rapidly and frozen in dry
ice. For analysis of diurnal expression and acute light induction,
animals were sacrificed at ZT6 and ZT18, the midpoints of the
light and dark phases, respectively. At ZT18, mice were either
sacrificed in dim (15-W) yellow light without receiving a light
pulse or were exposed to a 1-hr white fluorescent light pulse (30
W, positioned 4 inches above animals) beginning at ZT18 and
returned to darkness for a half-hour after the end of the light
pulse before sacrifice. For analysis of expression in DD, animals
were transferred to constant darkness at the usual lights-off time
and then sacrificed 22 or 34 hr later. Mice were dislocated
cervically, and the optic nerves were cut by using an infrared
viewer (FJW Industries, Palatine, IL); dissections were com-
pleted with dim, red (15-W, Kodak safelamp filter 1A) illumi-
nation. 33P[UTP]-labeled riboprobes were generated from tem-
plate DNA containing nucleotides 340–761 (GenBank accession
no. AF022992) and 9–489 (GenBank accession no. AF035830)
for mPer1 and mPer2, respectively. Sections (20 mm) throughout
the extent of the SCN were collected such that alternate sections
from the same brains were hybridized for mPer1 and mPer2.
Autoradiograms (Kodak BioMax MR) were digitized by using a
Polaroid SprintScan slide scanner and optical densities were
quantitated by using NIH IMAGE software on a Macintosh
computer. Signals were calibrated by comparison of optical
densities obtained from the same film exposed to 14C radioactive
standards (American Radiolabeled Chemicals, St. Louis) in-
serted into each film cassette. Effects of genotype, time, or
conditions or their interactions were analyzed by ANOVA using
NCSS, with Scheffe’s test for posthoc pairwise comparisons.
Results
Generation of Cry12y2 and Cry12y2Cry22y2 Mice. The Cry22y2
mice have been described previously (12). The Cry12y2 were
generated by the same approach using the targeting strategy
summarized in Fig. 1A. The transmission of the mutated gene
was determined by Southern hybridization. The original het-
erozygotes obtained by gene targeting then were crossed with
C57BLy6 to obtain Cry11y2 mice. The Cry12y2 mice were
obtained by mating these heterozygotes. Genotyping was done
by both Southern hybridization and PCR. Fig. 1B shows the
results of a genotyping assay by Southern hybridization. The
Cry12y2 mice were represented at the expected Mendelian
frequency and, hence, appear to have no survival disadvantage.
To obtain Cry12y2Cry22y2 mice, the Cry1 heterozygotes were
crossed with Cry22y2 mice to obtain Cry12y1Cry22y1 progeny.
The double heterozygotes were then interbred to obtain
Cry12y2Cry22y2 animals (Fig. 2). The double homozygous
mutants, as well, occurred at the predicted frequency and
appeared physically indistinguishable from their wild-type lit-
termates.
Circadian Behavior of Cry12y2 and Cry12y2Cry22y2 Mice. In previ-
ous work, Cry22y2 mice were found to have abnormal circadian
Fig. 1. Targeted disruption of the Cry1 gene. (A) Targeting of the Cry1 locus.
The construct (1) was used to target the Cry1 gene (2) in the E14 g2a embryonic
stem cell line. Homologous recombination leads to the deletion of a 13-kb
genomic region [stippled box in (2)] containing exon sequences encoding the
FAD-binding domain. The targeted allele (3) is detected by a probe as shown,
with the expected DNA fragment sizes as indicated. Solid boxes, identified
coding sequences; SA, Engrail-2 splice acceptor; S, SalI; Xb, XbaI; Xh, XhoI
(restriction sites). (B) Identification of targeted mutants by Southern hybrid-
ization. The 2.5-kb mutant and the 6.6-kb wild-type fragments resulting from
Xba digestion are indicated.









behavior, but were still capable of entrainment to light (12). It
was suggested that the photic response in these mutants was
mediated by either the CRY1 protein or a nonrod and noncone
opsin (12). Hence, it was of interest to determine the effects of
the Cry12y2 genotype both with regard to the free-running
period and entrainment to lightydark cycles. Fig. 3 A and B
shows that under LD12:12 conditions the mutants are indistin-
guishable from wild-type littermates, consistent with normal
photoentrainment. Interestingly, as in the case of Cry22y2 mice,
the Cry12y2 animals exhibit an altered free-running period
under DD conditions (Fig. 3B). However, in contrast to Cry22y2
mice (Fig. 3C), which have a free-running period 1 hr longer than
normal (Fig. 3A), Cry12y2 mice exhibit significantly shorter
free-running periods than wild type (Fig. 3E; GLM ANOVA,
F(5) 5 12.2, P , 1 3 1027; Scheffe’s posthoc comparison, P #
0.05). Thus, it appears that both CRY1 and CRY2 proteins can
influence the steady-state periodicity of the circadian system in
mice, but apparently ‘‘pull’’ the oscillator in opposite directions.
Because CRY1 and CRY2 mutants are still capable of en-
trainment to light, we analyzed mice lacking both cryptochromes.
The locomotor activity rhythms of Cry12y2Cry22y2 mice (Fig.
3D) under LD12:12 conditions appeared normal. However,
upon transfer to DD, the double mutants became arrhythmic
immediately (Fig. 3 D and F). Some weakening in circadian
rhythmicity is also apparent in Cry22y2 mice. For comparison,
activity records of Cry22y2 mice kept under identical conditions
were subject to the same FFT analysis as the individuals in the
present study. A significant reduction in relative power in the
circadian range is seen in Cry22y2 mice compared with wild-type
mice (GLM ANOVA, F(6) 5 2.81, P 5 0.02; Scheffe’s posthoc
comparison, P # 0.05). Yet, a more substantial reduction in
circadian power is observed in the double mutants (Fig. 3F;
GLM ANOVA, F(6) 5 2.81, P 5 0.02; Scheffe’s posthoc
comparison, P # 0.05). These results show that, jointly, the two
cryptochromes are essential for the expression of sustained
circadian rhythms of locomotor behavior in vivo. The complete
lack of residual circadian rhythmicity in DD is striking and
differs from that seen in Clock and mPer2 mutant mice (21,
23, 27).
Status of the Molecular Clock in Cry12y2 and Cry12y2Cry22y2
Mutants. The central role of cryptochromes in controlling be-
havioral circadian rhythms makes it difficult to distinguish their
putative role as photoreceptors from a role within the core
oscillator itself. Hence, we wished to analyze the circadian
pacemaker in the SCN and its response to light at the molecular
level to address this issue. Currently, the known likely compo-
nents of the molecular oscillator in mouse are Clock (21–23),
BMAL1 (28–29), and mPer1, mPer2, mPer3, and mTim (26, 27,
30–32), of which mPer1 and mPer2 show robust circadian
oscillations of gene expression and light induction in the SCN
(see ref. 3). Hence, we examined the oscillations of mPer1 and
mPer2 transcript levels and their induction by acute light pulses
to assess the roles of CRY1 and CRY2 proteins in photorecep-
tion as well as in the intrinsic oscillations of the molecular clock.
Fig. 4 A and B shows the effects of Cry genotype on mPer1
expression in the SCN under LD12:12 and in response to an
acute light pulse at ZT18. As would be expected, mPer1 levels
were elevated significantly during the day (ANOVA, F(1) 5
20.02, P , 0.005) and in response to light pulses (ANOVA,
F(1) 5 6.25, P , 0.05). Significant genotype by light-condition
interactions were detected (ANOVA, F(2) 5 5.56, P , 0.05),
reflective of differential response to light among the genotypes.
In particular, Cry12y2 mice had diminished light induction at
ZT18 (only '30% of wild type; Scheffe’s posthoc comparison,
P # 0.05) and Cry12y2 Cry22y2 mutants had significantly
elevated nocturnal levels with no significant induction in re-
sponse to light (Scheffe’s posthoc comparison, P # 0.05). The
nocturnal elevation of mPer1 mRNA levels is consistent with a
light-independent negative regulation by CRY1 and CRY2. In
Fig. 2. Genotyping of progeny from Cry11y2Cry21y2 cross by PCR. The
knockouts of both genes each were generated by deleting a segment of the
wild-type gene encoding the FAD-binding domain of CRY1 (amino acids
230–549) and of CRY2 (amino acids 349–569) and replacing it with the Neo
gene. As shown in the schematic diagram, primers hybridizing to the deleted
region were used to detect the wild type and primers hybridizing to the Neo
gene were used to detect the mutated genes. The photograph shows results
of PCR analysis of wild-type, double heterozygous, and double homozygous
mutant mice.
Fig. 3. Effects of disruption of the Cry genes on circadian locomotor activity
rhythms. (A–D) Wheel-running activity records of individual mice, double-
plotted according to convention so that each day’s data are represented both
to the right and beneath that of the preceding day. Times of activity are
represented by black. The animals were kept on a LD12:12 cycle as indicated
by the bar above each record and then transferred to constant darkness by
allowing lights to go off at the usual time on the day, indicated by an arrow
on the right. (A) Activity record of a wild-type mouse. (B) Activity record of a
Cry12y2 mouse. (C) Activity record of a Cry22y2 mouse. (D) Activity record of
a Cry12y2Cry22y2 mouse. (E) Effects of disruption of the Cry genes on circa-
dian period. The free-running period was estimated by x2 periodogram from
days 1–20 in DD. Means and SEM of each genotype are illustrated. Sample sizes
(N) are as follows: wild-type, n 5 6; Cry12y2, n 5 5; Cry22y2, n 5 10;
Cry12y2Cry22y2, n 5 4. None of the double homozygotes exhibited significant
circadian periodicity and, hence, no period estimates are shown. (F) Loss of
circadian rhythmicity was assessed by Fourier analysis. Data from days 1–20 in
DD were analyzed by fast Fourier transform (FFT), and power spectral densities
for frequencies ranging from 0 to 1 cyclesyhr were determined and normal-
ized to a total power (area under the curve) of one. The resultant relative
power value peak in the circadian range (18- to 30-hr period or 0.033- 0.055
cyclesyhr) was determined for each animal for comparison. The means and
SEM of circadian peak values of relative power are plotted for each genotype.
Sample sizes are the same as in E.
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addition, the absence of an acute light response of mPer1
suggests either that CRY1 and CRY2 are required for this
photoresponse or that there is a ceiling effect on mPer1 induc-
tion.
The mPer2 results, shown in Fig. 4 C and D, were quite
different. As with mPer1, significant elevation during the day
(ANOVA, F(1) 5 57.38, P 5 0.0003) or in response to an acute
light pulse (ANOVA, F(1) 5 210.2, P 5 0.000007) was present.
However, the day–night differences and photic induction were
exhibited by all three genotypes, so that no significant genotype
interaction was detected by ANOVA. However, a significant
main effect of genotype was present (ANOVA, F(2) 5 21.52, P 5
0.002) because of elevated levels in all conditions in the Cry12y2
Cry22y2 mutants relative to wild type (Scheffe’s posthoc com-
parison, P , 0.05). Thus, there is an unexpected difference in the
regulation of mPer1 and mPer2 in Cry double mutants.
To determine whether the day–night difference in mPer2 was
a light-driven or true circadian oscillation, we sought to deter-
mine whether either or both of the mPer transcripts were
continuing to oscillate in DD in the Cry12y2 Cry22y2 mice. Two
time points in DD (22 and 34 hr, or approximately CT 10 and 22)
were selected corresponding to the peak and trough times for
mPer2 in the SCN of wild-type mice. As shown in Fig. 5 A and
B, in the Cry12y2 Cry22y2 mice, there is no apparent oscillation
of mPer1 in DD and levels are constitutively elevated, consistent
with the observations under LD conditions. ANOVA revealed
significant genotype, time, and genotype 3 time interactions
(GLM ANOVA; genotype: F(1) 5 28.64, P , 0.002; time: F(1) 5
10.13, P , 0.02; genotype 3 time: F(1) 5 12.97, P , 0.02).
However, the results with mPer2 expression in DD conditions
contrasted to those seen in response to light and were similarly
invariant as mPer1 but at intermediate values (Fig. 5 C and D).
Because the mPer2 mean values of the mutants were not
different from wild types, ANOVA failed to detect a significant
Fig. 4. Effects of disruption of the Cry genes on diurnal expression of mPer1 and mPer2. (A) Representative in situ mPer1 signal in the SCN regions of mice of
three different genotypes and under three different conditions. (B) Means and ranges in signal values for mPer1 in the SCN by timeylight condition and genotype.
(C) Representative in situ mPer2 signal in the SCN regions of mice of three different genotypes and under three different conditions. (D) Means and ranges in
signal values for mPer2 in the SCN by timeylight condition and genotype. n 5 2 per genotype per condition.
Fig. 5. Effects of disruption of the Cry genes on circadian expression of
mPer1 and mPer2. (A) Representative in situ mPer1 signal in the SCN regions
of wild-type and Cry12y2Cry22y2 mutant mice and at two times in DD. (B)
Means and ranges in signal values for mPer1 in the SCN by time and genotype.
(C) Representative in situ mPer2 signal in the SCN regions of wild-type and
Cry12y2Cry22y2 mutant mice and at two times in DD. (D) Means and ranges
in signal values for mPer2 in the SCN by time and genotype. n 5 3 wild types;
two mutants per condition.









genotype effect; however, significant time effects and time 3
genotype interactions were detected (GLM ANOVA; genotype:
F(1) 5 0.98, P 5 0.36; time: F(1) 5 149.2, P , 0.00002;
genotype 3 time: F(1) 5 83.09, P , 0.0001). Thus, the lack of
circadian oscillations in mPer1 and mPer2 gene expression in
Cry12y2 Cry22y2 is consistent with behavioral arrhythmicity in
these animals under DD conditions (Fig. 3D).
Discussion
Our results raise a number of issues regarding the potential role
of cryptochromes as circadian photoreceptors and as integral
components of the molecular clock. It is still difficult to place the
cryptochromes definitively within the pathways that comprise
the circadian system; however, with the information at hand,
certain provisional conclusions can be made.
Cryptochromes as Circadian Photoreceptors. Elimination of either
CRY1 or CRY2 protein reduces and elimination of both abol-
ishes the acute light inducibility of mPer1 in the SCN. Both
sensitivity and phase of light induction of mPer1 correlate with
behavioral phase shifts, leading to the proposal that this may be
a mechanism by which light resetting of the circadian clock
occurs (33). Considering the photoreceptor function of all other
members of their class of proteins (5, 6), the simplest interpre-
tation is that CRY1 and CRY2 are circadian photoreceptors. In
agreement with this notion, genetic evidence in A. thaliana (14)
and Drosophila (13, 15, 16) show that cryptochromes act as
circadian photoreceptors in these organisms. Furthermore, it is
now well established that mice lacking rod and cone photore-
ceptor cells have normal circadian photoentrainment (34–36),
which is consistent with the claim that cryptochromes in the
ganglion cells and inner nuclear layer of the retina are the
circadian photoreceptors (8). However, the diurnal variation of
mPer2 in the SCN and its normal inducibility by acute light
pulses, combined with the finding that mPer2 may be a compo-
nent of the circadian clock (27), would seem to indicate that
there are at least two photic input pathways into the clock as has
been proposed for Drosophila (13). Indeed, in recent years a
number of nonrod, noncone opsins have been identified in
mammals (see ref. 37) that conceivably could act as circadian
photoreceptors in rodless and coneless mice. Clearly, there will
be no formal proof that cryptochromes are circadian photore-
ceptors until the photoreception and phototransduction mech-
anisms are understood at molecular detail.
The apparent rhythmicity, both behavioral and in mPer2
expression in Cry12y2Cry22y2 mice under LD conditions, raises
the question of whether this can be more appropriately termed
entrainment or ‘‘masking.’’ Masking refers to the obscuring of
the period phase, or presenceyabsence of a circadian rhythm, by
the response to a light pulse or other environmental Zeitgeber.
In a nocturnal rodent, activity onset may be delayed until
lights-off, for example, by the animal’s reluctance to move about
in a brightly lit environment. In a narrow sense, the term masking
would seem not to apply because there is no need to assume the
behavior is driven by factors other than the clock mechanism;
after all, mPer2 expression continues to change. However,
entrainment also seems inappropriate because both the behav-
ioral and mPer2 rhythms seem to be abolished within the first
cycle in constant conditions. A more appropriate term, hence,
seems to be ‘‘light-driven.’’ The correspondence between the
mPer2 expression and the behavioral rhythm could indicate that
mPer2 is more closely involved in driving behavior than other
clock genes. If this were so, then a light-driven mPer2 rhythm
could, in turn, drive a behavioral rhythm.
Cryptochromes as Clock Components. The data presented here and
by others (17) provide in vivo evidence that cryptochromes play
a central role within the mammalian circadian clock system.
First, mutations in either Cry1 or Cry2 alter the length of the
circadian period in mice in vivo. Second, in Cry12y2Cry22y2
double mutants there is no behavioral rhythmicity and no
molecular oscillation of either mPer1 or mPer2, which are
thought to be components of the molecular clock (31, 32).
Finally, Cry1, like many of the other clock genes, is expressed
with a circadian rhythm in the SCN (8). Whether the behavioral
arrhythmicity seen at the organismal level is a cell-autonomous
effect in SCN neurons (4) or is the result of desynchrony of SCN
cellular oscillators remains to be determined. In either case, it is
conceivable that the cryptochromes could exert their circadian
phenotypic effects at the level of input pathways to the circadian
oscillator system; however, the molecular effects on mPer gene
expression suggest a more central role. One caveat here is that
in Drosophila, which has a circadian photoreception system
similar to those of mammals (1, 3), it has been reported that the
absence of cryptochrome affects photoentrainment but not the
free-running period (13). However, the mutant used in that study
had a conservative change (Asp3Asn) at the flavin-binding site
(13). Conceivably, this mutation could abolish the photoreceptor
function but not affect the light-independent clock function.
Model for the Mammalian Clock. We have made three striking
molecular observations in this study: (i) the levels of mPer1 and
mPer2 transcripts in Cry12y2Cry22y2 are elevated under LD
conditions; (ii) the absence of diurnal variation of mPer1 but
near-normal variation of mPer2 in the double mutant under LD;
and (iii) the absence of apparent oscillations of both mPer1 and
mPer2 in CRY double mutants under DD conditions. These
results are consistent with cryptochromes playing a photorecep-
tive role as well as acting as regulators of mPer gene expression
in light-dependent (Fig. 4) and light-independent (Fig. 5) path-
ways.
That the basal levels of mPer1 increase in Cry12y2 and
Cry12y2Cry22y2 mice and that overall levels of mPer2 in LD are
elevated in Cry12y2Cry22y2 suggest that CRY proteins inhibit
mPer gene expression. This could occur by one of the following
mechanisms: CRY1 and 2 proteins could be repressors of the
mPer genes; CRY1 and 2 proteins could interact with CLOCK
or BMAL1 and interfere with the positive activation of mPer
transcription; or CRY1 and CRY2 could interact with PER and
TIM proteins and interfere with their negative feedback on the
CLOCK-BMAL1 complex. At present, we cannot differentiate
among these possibilities. However, by using recombinant CRY1
and CRY2 proteins, we failed to detect interaction with the E
box regulatory element of the mPer1 gene and with the CLOCK
protein made by in vitro transcriptionytranslation. However, we
did detect weak interactions of CRY with TIM and PER proteins
made by in vitro transcriptionytranslation (C.P.S., E. Vagas, and
A.S., unpublished data). In a recent cotransfection study, Kume
et al. (38) present data indicating that PER-CRY can negatively
affect CLOCK-BMAL1-driven mPer1 transcription. Our results
provide in vivo evidence of such a negative feedback role of Cry
genes on mPer1. The damping of mPer2 expression in
Cry12y2Cry22y2 mutants toward an intermediate value could
indicate either a diminished negative feedback on mPer2 as
compared with mPer1 or that the Cry genes’ influence on mPer2
is offset by some positive influence. The differential effect of the
two Cry genes on period raises the possibility that they have
differential effects on mPer2 as well.
In either case, it is apparent that the Cry genes differentially
influence mPer1 and mPer2 transcription. Differences in both
the timing and the phases at which light can induce these
transcripts in the SCN (30, 39) and, apparently, the phenotype
of the null (27) all suggest that these two genes have nonredun-
dant functions. To what extent their regulation by cryptochromes
are involved in the differences in the functions of mPer1 and
mPer2 remains to be determined.
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Thus, taken together, we propose the working model for the
mammalian clock system shown in Fig. 6. CRY1 and CRY2
could participate in the circadian transcription–translation feed-
back loop and, in addition, act as the dominant photoreceptive
elements for mPer1 acute light responses. In addition, there is
photic input by another photoreceptor, which either directly or
indirectly induces mPer2 acute light responses. Within the cir-
cadian feedback loop, both CRYs could interact with the other
clock proteins, such as PER and TIM, to provide negative
feedback (because in their absence mPer levels are elevated).
The two CRY proteins may work synergistically in some roles
(e.g., in their role related to the expression of circadian behav-
ioral and mPer rhythms) and antagonistically in others (e.g.,
affecting the free-running period in opposite directions). Clearly
more work is needed to develop a more specific model. This
awaits the elucidation of the significance of the interaction of
CRY1 and 2 with other signaling molecules such as phospho-
protein phosphatase 5 (40) as well as development of an in vitro
assay for the photochemical reaction catalyzed by cryptochrome.
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Fig. 6. The dual role of cryptochromes in the circadian clock. A model of genetic
interactions among cryptochromes and other elements in the circadian autoreg-
ulatory loop are shown. A presumed basic feedback loop of positive mPer
transcriptional drive of CLOCK-BMAL1 inhibited by PER-TIM is depicted. Crypto-
chromes appear to mediate light induction of mPer1 but not mPer2 (left side). In
addition, the potential for cryptochromes to dimerize with PERs suggests that
they may both function in a negative feedback as well (right side).
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